RU2016141650A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016141650A3 RU2016141650A3 RU2016141650A RU2016141650A RU2016141650A3 RU 2016141650 A3 RU2016141650 A3 RU 2016141650A3 RU 2016141650 A RU2016141650 A RU 2016141650A RU 2016141650 A RU2016141650 A RU 2016141650A RU 2016141650 A3 RU2016141650 A3 RU 2016141650A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014064590 | 2014-03-26 | ||
JP2014-064590 | 2014-03-26 | ||
PCT/JP2015/059026 WO2015147020A1 (ja) | 2014-03-26 | 2015-03-25 | アミド化合物 |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2016141650A RU2016141650A (ru) | 2018-04-27 |
RU2016141650A3 true RU2016141650A3 (ru) | 2018-11-12 |
RU2684906C2 RU2684906C2 (ru) | 2019-04-16 |
Family
ID=54195532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2016141650A RU2684906C2 (ru) | 2014-03-26 | 2015-03-25 | Амидные соединения |
Country Status (14)
Country | Link |
---|---|
US (1) | US10106523B2 (ru) |
EP (1) | EP3124480B1 (ru) |
JP (1) | JP6428763B2 (ru) |
KR (1) | KR20160138098A (ru) |
CN (1) | CN106132945B (ru) |
AR (1) | AR099833A1 (ru) |
CA (1) | CA2943778A1 (ru) |
ES (1) | ES2684334T3 (ru) |
MX (1) | MX368098B (ru) |
PL (1) | PL3124480T3 (ru) |
PT (1) | PT3124480T (ru) |
RU (1) | RU2684906C2 (ru) |
TW (1) | TW201623277A (ru) |
WO (1) | WO2015147020A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CR20180323A (es) | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
ES2893452T3 (es) | 2017-05-18 | 2022-02-09 | Idorsia Pharmaceuticals Ltd | Derivados de pirimidina como moduladores del receptor de PGE2 |
TW201900180A (zh) | 2017-05-18 | 2019-01-01 | 瑞士商愛杜西亞製藥有限公司 | 嘧啶衍生物 |
CA3063632A1 (en) | 2017-05-18 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | Benzofurane and benzothiophene derivatives as pge2 receptor modulators |
MA49128A (fr) | 2017-05-18 | 2021-03-17 | Idorsia Pharmaceuticals Ltd | Dérivés de pyrimidine utilisés en tant que modulateurs des récepteurs des pge2 |
PE20191787A1 (es) | 2017-05-18 | 2019-12-24 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituidos |
KR20230107228A (ko) | 2020-11-13 | 2023-07-14 | 오노 야꾸힝 고교 가부시키가이샤 | Ep4 길항약과 면역 체크포인트 저해 물질의 병용에 의한 암 치료 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003099857A1 (en) * | 2002-05-23 | 2003-12-04 | Theratechnologies Inc. | Antagonistic peptides of prostaglandin e2 receptor subtype ep4 |
US8969394B2 (en) | 2006-08-11 | 2015-03-03 | Merck Frosst Canada Ltd. | Thiophenecarboxamide derivatives as EP4 receptor ligands |
EP2172447A4 (en) * | 2007-07-03 | 2011-08-24 | Astellas Pharma Inc | amide |
DK2565191T3 (da) * | 2008-05-14 | 2014-11-10 | Astellas Pharma Inc | 4-(Indol-7-ylcarbonylaminomethyl)cyclohexancarboxylsyrederivater som EP4-receptorantagonister der er anvendelige til behandlingen af kronisk nyresvigt eller diabetisk nephropati |
ES2610185T3 (es) * | 2010-09-21 | 2017-04-26 | Eisai R&D Management Co., Ltd. | Composición farmacéutica |
WO2012103071A2 (en) | 2011-01-25 | 2012-08-02 | Eisai R&D Management Co., Ltd. | Compounds and compositions |
-
2015
- 2015-03-24 TW TW104109378A patent/TW201623277A/zh unknown
- 2015-03-25 PT PT15770149T patent/PT3124480T/pt unknown
- 2015-03-25 RU RU2016141650A patent/RU2684906C2/ru active
- 2015-03-25 PL PL15770149T patent/PL3124480T3/pl unknown
- 2015-03-25 US US15/127,574 patent/US10106523B2/en active Active
- 2015-03-25 CA CA2943778A patent/CA2943778A1/en not_active Abandoned
- 2015-03-25 WO PCT/JP2015/059026 patent/WO2015147020A1/ja active Application Filing
- 2015-03-25 ES ES15770149.1T patent/ES2684334T3/es active Active
- 2015-03-25 KR KR1020167027923A patent/KR20160138098A/ko active IP Right Grant
- 2015-03-25 JP JP2016510404A patent/JP6428763B2/ja active Active
- 2015-03-25 EP EP15770149.1A patent/EP3124480B1/en active Active
- 2015-03-25 AR ARP150100875A patent/AR099833A1/es unknown
- 2015-03-25 MX MX2016012318A patent/MX368098B/es active IP Right Grant
- 2015-03-25 CN CN201580016273.8A patent/CN106132945B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
MX368098B (es) | 2019-09-19 |
ES2684334T3 (es) | 2018-10-02 |
PT3124480T (pt) | 2018-10-04 |
CN106132945A (zh) | 2016-11-16 |
EP3124480A4 (en) | 2017-11-22 |
WO2015147020A1 (ja) | 2015-10-01 |
AR099833A1 (es) | 2016-08-24 |
CN106132945B (zh) | 2019-04-26 |
PL3124480T3 (pl) | 2018-10-31 |
KR20160138098A (ko) | 2016-12-02 |
EP3124480B1 (en) | 2018-07-11 |
CA2943778A1 (en) | 2015-10-01 |
MX2016012318A (es) | 2017-02-23 |
US20180030030A1 (en) | 2018-02-01 |
US10106523B2 (en) | 2018-10-23 |
TW201623277A (zh) | 2016-07-01 |
RU2684906C2 (ru) | 2019-04-16 |
JPWO2015147020A1 (ja) | 2017-04-13 |
JP6428763B2 (ja) | 2018-11-28 |
EP3124480A1 (en) | 2017-02-01 |
RU2016141650A (ru) | 2018-04-27 |